Skip to content

CYPH CYPH Return on equity

Return on equity at other companies

Pfizer logo
PfizerPFE
10.6%
Merck & Co. logo
Merck & Co.MRK
19%-20.3pp
Amgen logo
AmgenAMGN
101.3%-4.4pp
MicroStrategy logo
MicroStrategyMSTR
28.2%+20.4pp
Ziff Davis logo
Ziff DavisZD
2.6%-1.6pp
Zscaler logo
ZscalerZS
-3.7%+2.3pp

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-58.2%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Calculated from CYPH’s reported figures.

Based on trailing twelve months.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's return on equity?
CYPH (CYPH) reported return on equity of -108.2% in Q1 2026.
How has CYPH's return on equity changed year-over-year?
CYPH's return on equity increased by 46.7% year-over-year, from -202.8% to -108.2%.
What is the long-term trend for CYPH's return on equity?
Over 3 years (2021 to 2025), CYPH's return on equity has grown at a -54.0% compound annual growth rate (CAGR), from -52.5% to 5.1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.